Form 8-K - Current report:
SEC Accession No. 0001193125-12-151354
Filing Date
2012-04-05
Accepted
2012-04-05 11:54:41
Documents
6
Period of Report
2012-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d329230d8k.htm 8-K 20326
2 UNDERWRITING AGREEMENT d329230dex11.htm EX-1.1 184237
3 OPINION OF TROYGOULD PC d329230dex51.htm EX-5.1 6493
4 PRESS RELEASE d329230dex991.htm EX-99.1 6754
5 PRESS RELEASE d329230dex992.htm EX-99.2 7280
6 GRAPHIC g329230galena_logo.jpg GRAPHIC 9345
  Complete submission text file 0001193125-12-151354.txt   239561
Mailing Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034
Business Address 310 N. STATE STREET SUITE 208 LAKE OSWEGO OR 97034 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 12744490
SIC: 2834 Pharmaceutical Preparations